Medical device innovation: Eluvia drug-eluting vascular stent system
Boston ScientificBoston Scientific’s Eluvia drug-eluting vascular stent system is a drug delivery device for the treatment of peripheral artery disease.
Eluvia uses a drug-polymer combination to deliver the chemotherapy drug paclitaxel over the course of a year. It has a hydrophobic Promus polymer that protects the drug from dissolving in the blood and allows for highly-controlled drug delivery to the target lesion. Eluvia reduces downstream particulates and has low systemic drug exposure with no measurable levels of paclitaxel in the bloodstream within 30 minutes, according to the company.